Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRbg Holdings Regulatory News (RBGP)

  • This share is currently suspended. It was suspended at a price of 0.89
  • There is currently no data for RBGP

Trading and Dividend Update

1 Aug 2019 07:00

RNS Number : 4545H
Rosenblatt Group PLC
01 August 2019
 

1 August 2019

Rosenblatt Group plc

("Rosenblatt", the "Company" or the "Group") 

Trading and Dividend Update 

Rosenblatt Group plc (AIM: RBGP), the professional services group, is pleased to announce the following trading update ahead of the publication of its interim results for the six months ended 30 June 2019 on 25 September 2019.

The Group is performing well and delivering year on year growth at high net margins. The Group's financial year is typically second-half weighted and it is expected that marginally more revenue will be recognised in the second half of the year. The Group expects to report full-year results in line with market expectations.

In terms of the Group's divisional performance, the trends reported at the time of the Company's full-year results for the year ended 31 December 2018 have continued.

The Group's main practice areas, which are focused on contentious law, namely Dispute Resolution and Employment, have continued to perform well. The number of litigation cases that the Group is working on is growing, especially those undertaken on a contingent basis, from which the Group can receive a high rate of return if successful.

As previously flagged, the Corporate division, which is focused on commercial transactions, remains impacted by the cautious business environment in part caused by Brexit uncertainty. When this uncertainty clears, the indications are that there will be an increase in the volume of transactions, which have been delayed, including M&A from which the Group will benefit.

The Group continues to make progress in terms of establishing its litigation funding arm. There are currently four cases under consideration for funding and seven in progress. The Group has started to successfully realise revenues from the sale of partial participation rights in its litigation assets to third parties as part of the Board's policy of generating returns from these assets while limiting its risk exposure to individual cases.

At the interim results, the Group expects to update investors on the accounting methodology that will be used to account for these cases on the balance sheet.

The Company's balance sheet remains strong. In line with the Group's dividend policy, the Company intends to pay an interim dividend for the six months to 30 June 2019 of 2p per share. This sum will be formally announced on 25 September 2019 and will be paid to shareholders on the register as at 4 October 2019.

Enquiries:

Rosenblatt Group plc

Nicola Foulston, CEO

 

 Via Newgate Communications

 

Stifel (Nominated Adviser and Broker)

Tel: +44 (0)20 7710 7600

Gareth Hunt

Stewart Wallace (QE)

Tom Marsh

 

 

Newgate Communications (for media enquiries)

Robin Tozer/Fiona Norman

Tel: +44 (0)20 3757 6880; rosenblatt@newgatecomms.com

 

About Rosenblatt Group plc

Rosenblatt Group plc is a professional services group, which includes one of the UK's leading dispute resolution practices. It provides a range of legal services to its diversified client base, which includes companies, banks, entrepreneurs and individuals. Complementing this is the Group's increasingly international footprint, advising on complex cross-jurisdictional cases in China, Israel, America and India. Rosenblatt's practice areas include dispute resolution, corporate, banking and finance, insolvency and financial restructuring, construction and projects, employment, financial services, IP/technology/media, real estate, regulatory and tax resolution.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCDMGFNVMDGLZM
Date   Source Headline
3rd Mar 20257:00 amRNSCancellation - RBG HOLDINGS PLC
17th Feb 20258:36 amRNSUpdate on Intention to Appoint Administrators
31st Jan 202512:35 pmRNSIntention to Appoint Administrators
31st Jan 20257:00 amRNSDirectorate Change
28th Jan 20257:30 amRNSSuspension - RBG Holdings Plc
28th Jan 20257:00 amRNSCompany Update and Suspension of Trading in Shares
24th Jan 20257:00 amRNSExtension of Exclusivity Period
22nd Jan 20257:00 amRNSDirectorate Change
10th Jan 20256:04 pmRNSExclusivity Period with Rosenblatt Law Limited
10th Jan 20257:00 amRNSBalance Sheet Update
8th Jan 20257:00 amRNSTermination-Ian Rosenblatt’s Consultancy Agreement
23rd Dec 20247:00 amRNSNotice of Requisition of General Meeting
8th Oct 20241:55 pmRNSPDMR / PCA Dealing
7th Oct 20245:28 pmRNSDirector/PDMR Shareholding
7th Oct 20244:56 pmRNSHolding(s) in Company
3rd Oct 20244:06 pmRNSDirectorate Change
30th Sep 20247:00 amRNSUnaudited Interim Results
11th Sep 20248:54 amRNSNotice of Results and Investor Presentation
30th Jul 20247:00 amRNSPre-Close Trading Update and Notice of Results
19th Jun 20242:11 pmRNSResult of AGM
8th May 20245:39 pmRNSHolding(s) in Company
2nd May 20244:53 pmRNSAnnual Report and Accounts and Notice of AGM
30th Apr 20247:00 amRNSResults for the Year Ended 31 December 2023
8th Apr 20243:37 pmRNSHolding(s) in Company
8th Apr 202412:43 pmRNSHolding(s) in Company
4th Apr 20247:00 amRNSNotice of Results & Investor Presentation
28th Mar 20241:00 pmRNSDisposal of Convex Capital & Directorate Change
14th Mar 20242:01 pmRNSDirector/PDMR Dealings
12th Mar 202411:50 amRNSResult of General Meeting
12th Mar 20247:00 amRNSAIM Rule 17 Schedule Two (g) Update
11th Mar 20247:00 amRNSResult of Retail Offer
28th Feb 202411:03 amRNSHolding(s) in Company
23rd Feb 20247:00 amRNSRetail Offer
22nd Feb 20243:33 pmRNSResult of Placing and Subscription
22nd Feb 20247:00 amRNSProposed Fundraising and Notice of GM
10th Jan 20241:56 pmRNSHolding(s) in Company
19th Dec 20235:24 pmRNSHolding(s) in Company
18th Dec 20237:00 amRNSTrading Update
11th Dec 20237:00 amRNSRefinancing and Convex Capital Update
29th Nov 20237:00 amRNSDirectorate Change
31st Oct 20237:00 amRNSConvex Capital Update
30th Oct 20237:00 amRNSStatement Confirming Settlement
5th Oct 20235:40 pmRNSHolding(s) in Company
3rd Oct 20235:30 pmRNSHolding(s) in Company
2nd Oct 20236:21 pmRNSPDMR / PCA Dealing
28th Sep 20237:00 amRNSUnaudited Interim Results
11th Sep 20237:00 amRNSNotice of Results
31st Jul 202312:42 pmRNSDirector/PDMR Shareholding
31st Jul 20237:00 amRNSIan Rosenblatt appointed as an Executive Director
27th Jul 20237:00 amRNSPre-close Trading and Business Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.